Boundless Bio, Inc.
BOLD
Last
$2.53
Day
-1.9%
1y
+101.6%
5y
-81.9%
52w
-18.4%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0424d
EMA 21
2.66
EMA 50
2.65
EMA 200
2.10
20d high
-11.9%
5y high
-83.1%
5y range
11th
Positions held
Your positionsBOLD isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
12
Hold
watch
Signal
Neutral
Target
$3.00
Stop
$2.37
Stop distance
6.3%
Target vs last
+18.6%
Fundamentals
| Market cap | $58.69M | Enterprise value | -$13.94M | Trailing P/E | — | Forward P/E | -2.63 |
| PEG | — | Price / book | 0.88 | Beta | 0.47 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -67.9% | ROA | -32.8% | Debt / equity | — |
| Current ratio | 9.48 | Free cash flow | -$30.55M | Analyst recommendation | none | Mean target | $4.00 |
| 52w high | $3.16 | 52w low | $0.96 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$23.7M | -$13.6M | -$12.9M | -$13.9M | -$15.7M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$24.4M | -$14.5M | -$14.0M | -$15.1M | -$17.1M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$58.2M | -$65.4M | -$49.4M | -$45.9M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$63.6M | -$73.3M | -$54.8M | -$46.5M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsBOLD · daily-8.8% over 14 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin